Fate Therapeutics (FATE) Files 5.25M Share Common Stock Shelf for SHareholders

September 12, 2016 4:12 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Fate Therapeutics (NASDAQ: FATE) filed a registration with the U.S. SEC to sell up to 5,250,000 shares of common stock on behalf of selling shareholders.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Related Entities

S3

Add Your Comment